Vlad Vitoc, Chief Executive Officer, 10% Owner at MAIA Biotechnology, Inc. (MAIA), bought 73,000 shares at $1.37 ($100K) on 2026-09-14, disclosed to the SEC on 2026-09-15.
CEO Vlad Vitoc purchased $100,010 worth of shares at $1.37, signaling confidence in the company's recent pivot to a crypto treasury strategy. This insider buying comes as the stock has rallied 6.06% over the past five days.
The stock is currently trading at $1.40, up 6.06% over the last five days and 5.26% over the last 90 days. Despite this recent momentum, the shares remain significantly below their 52-week high of $3.19, down 56.11% from that peak.
1) Q3 earnings on October 29, 2025; 2) TheStreet reported on October 7, 2025, that MAIA Biotechnology's Board approved allocating up to 90% of its treasury to crypto.
The stock is down 18.13% over the last year and is currently trading at a forward P/E of 1.25, which may indicate high volatility or valuation concerns.
Something here stands out, but not much.
| Filing → |
| MAIA | BUY | 2025-12-04 | $10K | — | Filing → |
| MAIA | BUY | 2025-11-25 | $12K | — | Filing → |
| MAIA | BUY | 2023-05-01 | $10K | — | Filing → |